Thomas Ichim is actually the lead scientist behind

Thomas Ichim is actually the lead scientist behind the hemaxellerate program...  The most recent post quotes;

"On June 5, 2013 Regen  entered into an agreement with Oregon Health & Science University (“License Agreement”) whereby Oregon Health & Science University (“OHSU”)  granted to the Regen  an exclusive, worldwide, royalty bearing license to US patent No. 6,821,513 “Method for enhancing hematopoiesis” issued Nov. 23, 2004 (“Patent Rights”) and a non-exclusive, worldwide, royalty bearing license to, among other items, all inventions that are the subject of the invention disclosure giving rise to, or that are described in, patent applications included in the Patent Rights that do not issue into patents. (“Know-How”)."

Which is Thomas Ichim's domain.

alternatively...

I am quite certain Thomas Ichim is the head scientist of regen biopharma.

"SAN DIEGO, CA--(Marketwire - Jun 26, 2012) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today Thomas E. Ichim, PhD has joined the management team of its Regen BioPharma, Inc. subsidiary as Chief Scientific Officer and Director of Research. Regen BioPharma is the company's translational medicine platform for the rapid commercialization of stem cell therapies.

Dr. Ichim is one of the leading authorities in the world on stem cell biology. To date, he has published 82 peer-reviewed articles and is co-editor of the textbook RNA Interference: From Bench to Clinical Translation. He is also inventor on over 30 patents and patent applications. He currently serves as the CEO of Medistem, Inc., was formerly chief of scientific development, and is the scientific founder / co-founder of Medvax Pharma, ToleroTech, bioRASI, and OncoMune.

David Koos, Chief Executive Officer of Bio-Matrix Scientific Group, stated: "Dr. Ichim is a seasoned biotechnology executive with a track record of scientific excellence. We now have a world-class team to lead our efforts to commercialize stem cell therapies."

(oh, the only reason for this post is to clarify what the last PR stated about hemaxellerate and Min)